EUVIMEDEUVIMED entdecken
LeitlinieÜbersichtsarbeit

Management of Intraocular Retinoblastoma: ICMR Consensus Guidelines

Rachna Meel, Suyash Kulkarni, Lata Singh, Girish Chinnaswamy, Venkatraman Radhakrishnan, Renu Madan, Archana Sasi, Tanvir Kaur, R S Dhaliwal, Sameer Bakhshi

Indian Journal of Pediatrics · 2024-11 · 91 (11) · 1166-1176

DOI: 10.1007/s12098-024-05095-0 ↗

Kurz gefasst

Leitlinie in der Zeitschrift Indian Journal of Pediatrics, online erschienen am 13.04.2024. Verfasst von Rachna Meel und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Oculoplasty and Ocular Oncology Services, Dr. Rajendra Prasad Centre of Ophthalmic Sciences, All India Institute of Medical Sciences, N…. Hauptthemen laut MEDLINE: Retinoblastoma, Retinal Neoplasms. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 45 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Retinoblastoma (RB) is the most common childhood intraocular malignancy. Delayed presentation due to a lack of awareness and advanced intraocular tumors are a common scenario in low-middle income countries (LMICs). Remarkable treatment advances have been made in the past few decades allowing globe salvage in advanced intraocular RB (IORB) including systemic chemotherapy with focal consolidation and targeted treatments like intraarterial chemotherapy and intravitreal chemotherapy. However, a lack of availability and affordability limits the use of such advances in LMICs. External beam radiotherapy, despite risk of second cancers in RB with germline mutations, still remains useful for recalcitrant RB not responding to any other treatment. When choosing conservative treatment for advanced IORB, the cost and long duration of treatment, morbidity from multiple evaluation under anesthesias (EUAs), side effects of treatment and risk of treatment failure need to be taken into account and discussed with the parents. In this article, the authors discuss the ICMR consensus guidelines on the management of IORB.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

RetinoblastomaRetinal NeoplasmsHumansConsensus

Stichwörter der Autor:innen

ClassificationConsensusGuidelineIntra-arterial chemotherapyIntra-vitreal chemotherapyIntraocular retinoblastomaIntravenous chemotherapy

Autor:innen und Institutionen

  • Department of Oculoplasty and Ocular Oncology Services, Dr. Rajendra Prasad Centre of Ophthalmic Sciences, All India Institute of Medical Sciences, New Delhi, 110 029, India. dr.rachnameel@gmail.com.
  • Department of Interventional Radiology, Tata Memorial Hospital, Parel, Mumbai, India.
  • Department of Pediatrics, All India Institute of Medical Sciences, New Delhi, India.
  • Department of Pediatric Oncology, Tata Memorial Hospital, Parel, Mumbai, India.
  • Department of Medical Oncology and Pediatric Oncology, Cancer Institute (W.I.A), Adyar, Chennai, India.
  • Department of Radiotherapy and Oncology, Post Graduate Institute of Medical Education and Research (PGIMER), Chandigarh, India.

Zitieren

APA

Meel, R., Kulkarni, S., Singh, L., Chinnaswamy, G., Radhakrishnan, V., Madan, R., Sasi, A., Kaur, T., Dhaliwal, R. S., & Bakhshi, S. (2024). Management of Intraocular Retinoblastoma: ICMR Consensus Guidelines. Indian Journal of Pediatrics, 91(11), 1166-1176. https://doi.org/10.1007/s12098-024-05095-0

Vancouver

Meel R, Kulkarni S, Singh L, Chinnaswamy G, Radhakrishnan V, Madan R, et al. Management of Intraocular Retinoblastoma: ICMR Consensus Guidelines. Indian Journal of Pediatrics. 2024;91(11):1166-1176. doi:10.1007/s12098-024-05095-0

BibTeX
@article{Meel2024,
  author = {Meel, Rachna and Kulkarni, Suyash and Singh, Lata and Chinnaswamy, Girish and Radhakrishnan, Venkatraman and Madan, Renu and Sasi, Archana and Kaur, Tanvir and Dhaliwal, R S and Bakhshi, Sameer},
  title = {Management of Intraocular Retinoblastoma: ICMR Consensus Guidelines},
  journal = {Indian Journal of Pediatrics},
  year = {2024},
  volume = {91},
  number = {11},
  pages = {1166--1176},
  doi = {10.1007/s12098-024-05095-0}
}
Kostenlos starten →